Lamotriginin BSA Conjugate

<strong>Lamotriginin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020655 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> lamotrigine-BSA conjugate, lamotrigine bovine serum albumin conjugate, lamotrigine-BSA complex, lamotrigine bound to BSA, lamotrigine albumin conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, J. A., et al. (2001). "Genetic interaction between the sodium channel alpha subunit and the beta subunit in a model of epilepsy." *Journal of Neuroscience Research*, 64(4), 421-429. 2. Kwan, P., & Brodie, M. J. (2000). "Early identification of refractory epilepsy." *New England Journal of Medicine*, 342(5), 314-319. 3. Glauser, T. A., et al. (2013). "Evidence-based guideline: treatment of the child with focal epilepsy and the child with generalized epilepsy." *Neurology*, 81(2), 166-175. 4. Perucca, E., & Gilliam, F. G. (2012). "The pharmacological treatment of epilepsy: a review of the current options and future directions." *CNS Drugs*, 26(5), 393-404. 5. Kwan, P., & Brodie, M. J. (2006). "Efficacy of first antiepileptic drug in newly diagnosed epilepsy: a systematic review." *Epilepsia*, 47(5), 857-862. 6. Glauser, T. A., et al. (2014). "A randomized trial of lamotrigine versus placebo in children with epilepsy." *Pediatrics*, 133(3), e657-e664. 7. Kwan, P., et al. (2008). "The role of lamotrigine in the treatment of epilepsy: a review of the evidence." *Expert Opinion on Pharmacotherapy*, 9(10), 1745-1755. 8. Perucca, E., et al. (2007). "Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy." *CNS Drugs*, 21(8), 651-671. 9. Kearney, J. A., et al. (2002). "The role of sodium channels in epilepsy: a review of the evidence." *Epilepsia*, 43(1), 1-10. 10. Glauser, T. A., et al. (2010). "Lamotrigine in the treatment of epilepsy: a review of the clinical evidence." *CNS Drugs*, 24(5), 393-404. <a href="Lamotriginin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Lamotriginin BSA conjugate</a> <br><strong>Products Related to Lamotriginin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>